Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China’s Aoxing, U.S.’s American Oriental Pair To Market Painkillers

This article was originally published in PharmAsia News

Executive Summary

China's Aoxing Pharmaceutical has signed an agreement with Oriental Bioengineering of the United States to develop and market painkillers and narcotics. The deal calls for American Oriental buying a 38 percent share of Aoxing for $18 million. Aoxing recently completed its acquisition of Shijazhuang Lerentang Pharmaceutical, also of China. Shijazhuang specializes in pain-management products. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts